Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G1K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G361 |
Human skin malignant melanoma cell line | ATCC CRL-1424 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G500 |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
GR-M |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
H357 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | N. Düzgünes et al., Methods in Enzymology, 2012, 509, DOI: 10.1016/B978-0-12-391858-1.00018-6 | ||||
H413 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | N. Düzgünes et al., Methods in Enzymology, 2012, 509, DOI: 10.1016/B978-0-12-391858-1.00018-6 | ||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | W. Xiao et al., Free Radical Biology and Medicine, 2013, 65: 70–77, doi.org/10.1016/j.freeradbiomed.2013.06.010 | ||||
HaCaT |
Human keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | L. Stixová et al., Life, 2021, 11, 669, doi.org/10.3390/life11070669 | Link | |||
hADMC |
Human primary adipose-derived mast cells | Human | immune system | primary cell | plasmid | Metafectene PRO | publication | M. Motaghed et al., J. Immuntherapy of Cancer, 2021, 9(Suppl 2): A1–A1052, doi.org/10.1136/jitc-2021-SITC2021.220 | Link | ||||
hAEC |
Human aortic endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 | Link | ||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | siRNA | Metafectene PRO | publication | E. J. Lee, Mol. Therapy, 2018, doi: 10.1016/j.ymthe.2017.12.015 | ||||
HCC-44 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
HCC-515 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link |